Eliquis
Apixaban, sold under the brand name Eliquis among others, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa. It is used as an alternative to warfarin to prevent blood clots following hip or knee replacement and in those with a history of prior clots and does not require monitoring by blood tests or dietary restrictions. It is taken by mouth.
Recent news mentioning Eliquis
- — Pfizer Raises Revenue Outlook as Eliquis Sales Drive Strong Quarter
- — Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis
- — Bristol Myers raises 2026 forecast as Eliquis, newer medicines power results